ChiCTR2300071420 版本V1.2 版本创建时间2023/08/24 20:03:27 中国临床试验注册中心

审核状态:

Project audit state:

通过审核

Successful

注册号:

Registration number:

ChiCTR2300071420 

最近更新日期:

Date of Last Refreshed on:

2023-06-05 12:36:13 

注册时间:

Date of Registration:

2023-05-15 00:00:00 

注册号状态:

补注册

Registration Status:

Retrospective registration

注册题目:

肺内源性ARDS长期机械通气的相关因素分析及预测模型构建

Public title:

Analysis of factors associated with prolonged mechanical ventilation and construction of a predictive model in?pulmonary ARDS

注册题目简写:

English Acronym:

研究课题的正式科学名称:

肺内源性ARDS长期机械通气的相关因素分析及预测模型构建

Scientific title:

Analysis of factors associated with prolonged mechanical ventilation and construction of a predictive model in?pulmonary ARDS

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

邵钫蕾/李济尾 

研究负责人:

陈丽 

Applicant:

fanglei shao/jiwei li 

Study leader:

li chen 

申请注册联系人电话:

Applicant telephone:

+86 137 7810 7496

研究负责人电话:

Study leader's telephone:

+86 189 9070 5166

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

3464781279@qq.com

研究负责人电子邮件:

Study leader's E-mail:

3464781279@qq.com

申请单位网址(自愿提供):

Applicant website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

申请注册联系人通讯地址:

南充市顺庆区茂源南路1号

研究负责人通讯地址:

南充市顺庆区茂源南路1号

Applicant address:

No.1 Maoyuan South Road, Shunqing District, Nanchong City

Study leader's address:

No.1 Maoyuan South Road, Shunqing District, Nanchong City

申请注册联系人邮政编码:

Applicant postcode:

637000

研究负责人邮政编码:

Study leader's postcode:

637000

申请人所在单位:

川北医学院附属医院

Applicant's institution:

Affiliated Hospital of North Sichuan Medical College

研究负责人所在单位:

川北医学院附属医院

Affiliation of the Leader:

Affiliated Hospital of North Sichuan Medical College

是否获伦理委员会批准:

是/Yes

Approved by ethic committee:

Yes

伦理委员会批件文号:

Approved No. of ethic committee:

2023ER063-1

伦理委员会批件附件:

Approved file of Ethical Committee:

查看附件View

批准本研究的伦理委员会名称:

川北医学院附属医院伦理委员会

Name of the ethic committee:

Medical Ethics Committee of Affiliated Hospital of North Sichuan Medical College

伦理委员会批准日期:

Date of approved by ethic committee:

2023-03-10 00:00:00

伦理委员会联系人:

杨汉丰

Contact Name of the ethic committee:

hanfeng yang

伦理委员会联系地址:

南充市顺庆区茂源南路1号

Contact Address of the ethic committee:

No.1 Maoyuan South Road, Shunqing District, Nanchong City

伦理委员会联系人电话:

Contact phone of the ethic committee:

+86 817 226 2124

伦理委员会联系人邮箱:

Contact email of the ethic committee:

3464781279@qq.com

研究实施负责(组长)单位:

川北医学院附属医院

Primary sponsor:

Affiliated Hospital of North Sichuan Medical College

研究实施负责(组长)单位地址:

南充市顺庆区茂源南路1号

Primary sponsor's address:

No.1 Maoyuan South Road, Shunqing District, Nanchong City

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

四川省

市(区县):

南充市

Country:

China

Province:

Sichuan Province

City:

单位(医院):

川北医学院附属医院

具体地址:

南充市顺庆区茂源南路1号

Institution
hospital:

Affiliated Hospital of North Sichuan Medical College

Address:

No.1 Maoyuan South Road, Shunqing District, Nanchong City

经费或物资来源:

研究者发起

Source(s) of funding:

Researcher initiated

Target disease:

acute respiratory distress syndrome

Target disease code:

研究类型:

观察性研究

Study type:

Observational study

研究所处阶段:

回顾性研究 

Study phase:

Retrospective study

研究设计:

队列研究 

Study design:

Cohort study 

研究目的:

ARDS病变的不均一性和血流动力学不稳定,使得ARDS患者更可能需要长时间机械通气。找出导致ARDS患者长期机械通气的危险因素是十分重要的。而肺内源性ARDS具有较高的发病率,因此我们旨在确定肺内源性ARDS患者机械通气时间延长相关的因素,并为延长机械通气创建新的预测评分。  

Objectives of Study:

ARDS's heterogeneity and hemodynamic instability require prolonged mechanical ventilation in patients with ARDS. It is incredibly important to identify risk factors for prolonged mechanical ventilation in patients with acute respiratory distress syndrome. Although the prevalence of pulmonary ARDS (ARDSp) is high, we aimed to identify factors and create a new predictive score for prolonged mechanical ventilation in patients with ARDSp.

药物成份或治疗方案详述:

 

Description for medicine or protocol of treatment in detail:

 

纳入标准:

纳入标准为:(1)年龄大于18周岁;(2)符合2012年柏林定义;(3)ICU治疗时间>24小时;(4)病历资料完整者。

Inclusion criteria

1. age >18 years 2. conform to the Berlin 2012 definition 3. duration of mechanical ventilation in the ICU ≥24 hours 4. those with complete medical records.

排除标准:

排除标准为:(1)入住ICU<24小时;(2)伴有心源性肺水肿、肺大泡或气胸、皮下气肿、纵隔气肿(3)合并肿瘤、自身免疫疾病或血液系统疾病、严重精神障碍。(4)病历资料不完整者。

Exclusion criteria:

1.duration of mechanical ventilation <24 hours 2.people with cardiogenic pulmonary oedema, pulmonary alveoli or pneumothorax, subcutaneous emphysema, mediastinal emphysema 3.people with tumours, autoimmune or haematological disorders, severe mental disorders 4.Those with incomplete medical records.

研究实施时间:

Study execute time:

From 2023-01-01 00:00:00 To 2024-01-01 00:00:00  

征募观察对象时间:

Recruiting time:

From 2023-03-12 00:00:00 To 2024-01-01 00:00:00  

干预措施:

Interventions:

组别:

肺内源性ARDS 机械通气患者(长期机械通气组/非长期机械通气患者)

样本量:

118

Group:

Mechanically Ventilated Patients of ARDSp(PMV group/Non-PMV group)

Sample size:

干预措施:

干预措施代码:

Intervention:

None

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

中国

省(直辖市):

四川省 

市(区县):

 

Country:

China 

Province:

Sichuan Province 

City:

 

单位(医院):

川北医学院附属医院 

单位级别:

三级甲等医院  

Institution
hospital:

Affiliated Hospital of North Sichuan Medical College

Level of the institution:

Tertiary hospital

测量指标:

Outcomes:

指标中文名:

14天长期机械通气

指标类型:

主要指标

Outcome:

prolonged Mechanical ventilation (14 days)

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

28天死亡率

指标类型:

次要指标

Outcome:

28-day mortality

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

APACHE II评分

指标类型:

次要指标

Outcome:

APACHE II scores

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

深静脉血栓

指标类型:

次要指标

Outcome:

Deep vein thrombosis

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

压疮

指标类型:

次要指标

Outcome:

Pressure ulcer

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

指标类型:

次要指标

Outcome:

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

征募研究对象情况:

Recruiting status:

正在进行

Recruiting

年龄范围:

Participant age:

最小 Min age 18 years
最大 Max age years

性别:

男女均可

Gender:

Both

随机方法(请说明由何人用什么方法产生随机序列):

回顾性研究,不涉及分组

Randomization Procedure (please state who generates the random number sequence and by what method):

Retrospective study, no grouping was involved

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

公开/Public

盲法:

Blinding:

试验完成后的统计结果(上传文件):

Calculated Results after
the Study Completed(upload file):

是否共享原始数据:

IPD sharing

No

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

ResMan

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

ResMan

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

数据采集和管理由两部分组成。首先我们使用电子采集和管理系统进行数据采集,研究中个人资料和病例信息由两名数据管理的专人录入,第二我们将所收集的数据以电子版的形式保存在专门的电脑中,不在用于其他目的

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

Data collection and management are composed of two parts.First we use an electronic capture and management system for data collection, with personal data and case information in the study entered by two dedicated data management staff,Second data will be stored in electronic form in a special computer, which will not be used for other purposes.

数据与安全监察委员会:

Data and Safety Monitoring Committee:

有/Yes

注册人:

Name of Registration:

 2023-05-15 15:38:38